"Metoprolol" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
| Descriptor ID |
D008790
|
| MeSH Number(s) |
D02.033.100.624.698.573 D02.033.755.624.698.573 D02.092.063.624.698.573
|
| Concept/Terms |
Metoprolol Succinate- Metoprolol Succinate
- Succinate, Metoprolol
- Metoprolol CR-XL
- CR-XL, Metoprolol
- Metoprolol CR XL
Betaloc- Betaloc
- Betaloc-Astra
- Betaloc Astra
- BetalocAstra
|
Below are MeSH descriptors whose meaning is more general than "Metoprolol".
Below are MeSH descriptors whose meaning is more specific than "Metoprolol".
This graph shows the total number of publications written about "Metoprolol" by people in this website by year, and whether "Metoprolol" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 1 | 0 | 1 |
| 1997 | 1 | 0 | 1 |
| 1999 | 2 | 0 | 2 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 1 | 1 |
| 2005 | 0 | 3 | 3 |
| 2006 | 1 | 1 | 2 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 2 | 2 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Metoprolol" by people in Profiles.
-
Reese Z, Ganatra RB. Metoprolol for the Prevention of Exacerbations of COPD. N Engl J Med. 2020 04 02; 382(14):1374.
-
Juraschek SP, Appel LJ, Miller ER, Mukamal KJ, Lipsitz LA. Hypertension Treatment Effects on Orthostatic Hypotension and Its Relationship With Cardiovascular Disease. Hypertension. 2018 10; 72(4):986-993.
-
Juraschek SP, Appel LJ, Miller ER. Metoprolol Increases Uric Acid and Risk of Gout in African Americans With Chronic Kidney Disease Attributed to Hypertension. Am J Hypertens. 2017 Sep 01; 30(9):871-875.
-
Badri M, Gibbons AV, Popii V, Yih D, Cohen-Stein DL, Patel SM. Perioperative management of a patient with a nonresectable pheochromocytoma. Endocr Pract. 2013 May-Jun; 19(3):e74-6.
-
Ramdas S, Riesenberg LA, Jasani N. Drug overdose with refractory bradycardia and hypotension. Del Med J. 2011 Jun; 83(6):169-72.
-
Weintraub WS, Spertus JA, Kolm P, Maron DJ, Zhang Z, Jurkovitz C, Zhang W, Hartigan PM, Lewis C, Veledar E, Bowen J, Dunbar SB, Deaton C, Kaufman S, O'Rourke RA, Goeree R, Barnett PG, Teo KK, Boden WE, Mancini GB. Effect of PCI on quality of life in patients with stable coronary disease. N Engl J Med. 2008 Aug 14; 359(7):677-87.
-
Sabri A, Rafiq K, Seqqat R, Kolpakov MA, Dillon R, Dell'italia LJ. Sympathetic activation causes focal adhesion signaling alteration in early compensated volume overload attributable to isolated mitral regurgitation in the dog. Circ Res. 2008 May 09; 102(9):1127-36.
-
Pleger ST, Most P, Koch WJ. Recent findings into the potential of gene therapy to reverse heart failure. Expert Opin Biol Ther. 2007 Dec; 7(12):1781-4.
-
Bowen FW, Civan J, Orlin A, Gleason T. Management of type A aortic dissection and a large pheochromocytoma: a surgical dilemma. Ann Thorac Surg. 2006 Jun; 81(6):2296-8.
-
Thornley-Brown D, Wang X, Wright JT, Randall OS, Miller ER, Lash JP, Gassman J, Contreras G, Appel LJ, Agodoa LY, Cheek D. Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease. Arch Intern Med. 2006 Apr 10; 166(7):797-805.